Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Eicosadienoyl-EA)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001680 AN002740 Metabolome of NAFLD in high fat diet mouse model Liver Mouse Fatty liver disease Weill Cornell Medicine Abundance
ST001795 AN002915 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) Mesenteric lymph Mouse Obesity Monash Institute of Pharmaceutical Sciences height
ST001796 AN002917 Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib Mesenteric lymph Mus musculus Diabetes Monash Institute of Pharmaceutical Sciences height
ST001788 AN002899 β-Adrenergic regulation of metabolism in macrophages (part-IV) Macrophages Human Monash University Intensity
ST002182 AN003574 Amelioration of developmental programming of NAFLD in weanling liver using PQQ Liver Mouse Fatty liver disease University of Oklahoma Health Sciences Center Peak area
ST002191 AN003586 Amelioration of developmental programming of NAFLD in fetal liver using PQQ Liver Mouse Fatty liver disease University of Oklahoma Health Sciences Center Peak area
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash Institute of Pharmaceutical Sciences, Monash University Peak height
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001275 AN002116 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001276 AN002117 Development and Characterisation of a Novel Class of Aroyl Guanidine Containing Anti-Trypanosomal Compounds Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST000422 AN000667 Type 1 Diabetes good glycemic control and controls samples Blood Human Diabetes Mayo Clinic Peak intensity
ST000551 AN000842 Investigating large scale metabolomics in mice tissue lacking insulin receptors and IGF-1 receptors Muscle Mouse Diabetes Mayo Clinic Peak intensity
ST002094 AN003420 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST002094 AN003421 Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) Feces Human Irritable bowel syndrome Mayo Clinic raw intensity
ST000046 AN000076 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000046 AN000077 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) Blood Human Alzheimers disease Mayo Clinic Raw MS Intensities
ST000047 AN000081 Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) Cerebrospinal fluid Human Alzheimers disease Mayo Clinic Raw MS Intensities
  logo